CXCL12 and acute lymphoblastic leukemia: Co-culturing ALL cells with bone marrow stromal cells (capable of producing CXCL12) generates drug resistance and protects ALL cells from chemotherapy-induced apoptosis, leading to further exacerbation of leukemia [103].